FDA Approves First Cell-Based Gene Therapy For Rare Skin Disorder

Authored by Zachary Stieber via The Epoch Times (emphasis ours),
The Food and Drug Administration (FDA) has approved Zevaskyn, a gene therapy for a rare skin disorder, the company that makes the product said on April…